Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

Affiliations

Comment

Kevin Cowart et al. JAMA. 2021.

. 2021 Oct 5;326(13):1329-1330.

doi: 10.1001/jama.2021.13472.

No abstract available

Comment in

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin-Reply.
Martens TW, Beck RW, Bergenstal RM. Martens TW, et al. JAMA. 2021 Oct 5;326(13):1330-1331. doi: 10.1001/jama.2021.13478. JAMA. 2021. PMID: 34609455 No abstract available.

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, McGill JB, Aleppo G, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Buse JB, Price D, Bergenstal RM; MOBILE Study Group. Martens T, et al. JAMA. 2021 Jun 8;325(22):2262-2272. doi: 10.1001/jama.2021.7444. JAMA. 2021. PMID: 34077499 Free PMC article. Clinical Trial.